Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Intarcia's annual diabetes treatment aces two Phase III trials
Fierce Biotech
Thursday, October 2, 2014 - 10:28am
tags:
Intarcia, diabetes, devices, ITCA 650
Analyst: Edwards Lifesciences' Sapien 3 poised to lead TAVI market
Mass Device
Thursday, October 2, 2014 - 9:43am
tags:
Edwards Lifesciences, Sapien 3, TAVI, devices
Eli Lilly to drop development of lupus drug
Yahoo/Reuters
Thursday, October 2, 2014 - 9:35am
tags:
Eli Lilly, lupus, tabalumab
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Thursday, October 2, 2014 - 9:33am
tags:
Celgene, Novartis, Eli Lilly, JNJ, Bristol-Myers Squibb, Biogen Idec
How Much? A Glaxo Goof Remains in the Sunshine Database
WSJ Pharmalot
Thursday, October 2, 2014 - 8:50am
tags:
GSK, physician payments, Physician Payment Sunshine Act
ISS Says Allergan Should Seek Shareholder Approval For Acquisition
Bidness Etc.
Thursday, October 2, 2014 - 8:48am
tags:
Allergan, Valeant Pharmaceuticals, M&A, ISS
Allergan blueprints a big Texas expansion amid battle with spendthrift Valeant
Fierce Biotech
Thursday, October 2, 2014 - 8:16am
tags:
Allergan, Texas, Valeant Pharmaceuticals, drug manufacturing
Sanofi sets up a major R&D hub in booming Shanghai
Fierce Biotech
Thursday, October 2, 2014 - 8:12am
tags:
Sanofi, R&D, China
Boehringer Ingelheim invests more than €100m to expand manufacturing capacity in Germany
In-Pharma Technologist
Thursday, October 2, 2014 - 8:10am
tags:
Boehringer Ingelheim, Germany, drug manufacturing
Genentech shift could prove costly for hospitals
Medical Marketing and Media
Thursday, October 2, 2014 - 8:06am
tags:
Genentech
Ariad Pharma's lung cancer drug gets breakthrough therapy status
Yahoo/AP
Thursday, October 2, 2014 - 8:04am
tags:
Ariad Pharmaceuticals, AP26113, FDA, lung cancer, breakthrough therapies
Sales rep restrictions point to need for a pharma rethink
Medical Marketing and Media
Wednesday, October 1, 2014 - 9:46pm
tags:
drug reps, physician access
[video]Inovio CEO: New Ebola vaccine effective in animals
CNBC
Wednesday, October 1, 2014 - 9:38pm
tags:
Inovio, ebola virus, vaccines
AstraZeneca Whale Racing With Minnow to Develop Lung Cancer Drug
Bloomberg
Wednesday, October 1, 2014 - 9:32pm
tags:
AstraZeneca, Clovis Oncology, lung cancer
Esperion shares rally on cholesterol drug study results
Marketwatch
Wednesday, October 1, 2014 - 6:41pm
tags:
Esperion Therapeutics, ETC-1002, Merck, Zetia
GSK, NewLink working to bring Ebola vaccines online - WHO
Yahoo/Reuters
Wednesday, October 1, 2014 - 6:33pm
tags:
GSK, NewLink Genetics, ebola virus, vaccines
Bayer launches US$7bn six-tranche acquisition bond
Yahoo/Reuters
Wednesday, October 1, 2014 - 6:27pm
tags:
Bayer, M&A, Merck, consumer health
Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review
Marketwatch
Wednesday, October 1, 2014 - 10:47am
tags:
Zogenix, Zohydro ER
Med tech attorneys say FDA ramping up monitoring of device promotion
Fierce Medical Devices
Wednesday, October 1, 2014 - 10:42am
tags:
FDA, devices
That Flushing Sound: Pharma Must pay for a Drug Take-Back Program
WSJ Pharmalot
Wednesday, October 1, 2014 - 9:30am
tags:
drug take-back programs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.